本文へ移動
受付中補助金Medical equipment and pharma

Portable and versatile Point-of-care diagnostics[E8]

UnknownEuropean Commission[E1]

分かりやすく

支援の内容
Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”.
応募できる人
  • EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
  • 段階: Prototype and MVP
日程
2026年10月29日 に受付開始。締切:
助成機関の締切:2027年2月17日, 01:00 中央ヨーロッパ時間 (UTC+1)。 UTC:2027年2月17日, 00:00 UTC。
資金
EUR 10,000,000 合計資金の種類: Grant。
資金提供者
European Commissionこの資金提供者の他の支援を見る。
募集要項と申請

募集要項、規則、申請書は資金提供者のページにあります。申請前にお読みください。

受付開始[E6]
2026年10月29日
締切[E2]
2027年2月17日, 01:00 中央ヨーロッパ時間 (UTC+1)
資金総額[E9]
EUR 10,000,000
1件あたり
記載なし
最終確認
5時間前

資金について

公告より

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Healthcare professionals dispose of diagnostic tools at the point of care that accelerate therapeutic decision making. Patients benefit from fast and accurate diagnosis leading to improved health outcomes. Thanks to more efficient diagnosis, health systems will get better evidence for disease control and prevention strategies. Scope: Point-of-Care (PoC) medical testing has made great technical progress (e.g. improved extraction, microfluidics, miniaturisation, and data processing techniques) with PoC test accuracies nearly matching those of lab-based tests. PoC tests may thus be an alternative to laboratory testing methods, enabling faster diagnostic results and therapeutic decision making. However, PoC testing is not always achieving a completely accurate diagnosis and one of the major issues with PoC diagnostics is the occurrence of false results during testing, another one is the often-cumbersome sample preparation. Hence there is a need for PoC diagnostics that are more sensitive, selective and easy-to-use allowing for improved clinical practice. The World Health Organization (WHO) has defined a set of …[E3]

応募できる人

公告の詳細は情報源が公開したとおりに表示しています。当社が抽出する事実と要件は英語で記載しています。

  • 条件EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

リスクと不明点

  • リスクThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
  • 不明We read the funder's listing, not the full guidance or application forms.

更新履歴

  1. 入札受付開始 · 2026年10月29日, 07:41 UTC

    The funder published the call with a future closing date.

    変更:status, notice type, published at (元の記録 Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage))

  2. 初回取得 · 2026年10月28日, 21:22 UTC

    The funder announced the call. Applications have not opened yet.

    元の記録: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)

根拠

9件の事実

このページの情報はすべて資金提供者の掲載情報からのものです。各項目に読み取った記録と項目名を示します。

  1. E1

    The funder is European Commission.

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/type/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  2. E2

    Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

    “2027-02-17T00:00:00.000+0000”

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/deadlineDate/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  3. E3

    The buyer describes the requirement in the notice.

    “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deli…”

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/descriptionByte/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  4. E4

    EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

    “EU call topic”

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/type/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  5. E5

    This is an EU call for proposals.

    “31094502”

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/status/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  6. E6

    Applications open on 29 Oct 2026.

    “2026-10-29T00:00:00.000+0000”

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/startDate/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  7. E7

    The Funding & Tenders Portal gives the status as open for submission.

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/status/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  8. E8

    The notice is titled "Portable and versatile Point-of-care diagnostics".

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/title/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

  9. E9

    The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

    出典: Portable and versatile Point-of-care diagnostics (ID HORIZON-HLTH-2027-02-IND-02-two-stage)、 項目 /metadata/budgetOverview/0, 2026年10月29日, 07:41 UTCに読み取り · 情報源 (新しいタブで開きます)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. データのライセンス: Creative Commons Attribution 4.0 (European Commission) (新しいタブで開きます). 公告に含まれる個人の連絡先は保存も表示もしません。